nr chairman not to seek re-election at agm, page-21

Mark Bouris is a financial man. No biotech out there in his resume.

So he was meant to be a deal closer, and a popular face to get ADO some attention.

Neither of which has happened.

Glad he has moved on. Good for him I'm sure, better for us.

Would like to see a chairman with biotech or technology experience, many years of experience and a solid reputation in financial circles. Not for being a financial whiz(aka MB) but for someone who has delivered financial results.

But ADO is very small(still...argh) so the calibre we will attract is a little limited.

I just hope its not a Diasource person otherwise this whole thing reeks of a reverse takeover and we dont have any idea where that would lead. Possibly private...which is my worst fear...